BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16309801)

  • 1. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains.
    Rubin S; Mauldin J; Chumakov K; Vanderzanden J; Iskow R; Carbone K
    Vaccine; 2006 Mar; 24(14):2662-8. PubMed ID: 16309801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003.
    Atrasheuskaya AV; Blatun EM; Kulak MV; Atrasheuskaya A; Karpov IA; Rubin S; Ignatyev GM
    Vaccine; 2007 Jun; 25(24):4651-8. PubMed ID: 17498853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004.
    Atrasheuskaya AV; Kulak MV; Rubin S; Ignatyev GM
    Clin Microbiol Infect; 2007 Jul; 13(7):670-6. PubMed ID: 17484765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
    Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
    J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping antigenic diversity and strain specificity of mumps virus: a bioinformatics approach.
    Kulkarni-Kale U; Ojha J; Manjari GS; Deobagkar DD; Mallya AD; Dhere RM; Kapre SV
    Virology; 2007 Mar; 359(2):436-46. PubMed ID: 17081582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reactions of monoclonal antibodies with structural proteins of mumps virus.
    Orvell C
    J Immunol; 1984 May; 132(5):2622-9. PubMed ID: 6201553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of mumps virus in Japan and proposal of two new genotypes.
    Inou Y; Nakayama T; Yoshida N; Uejima H; Yuri K; Kamada M; Kumagai T; Sakiyama H; Miyata A; Ochiai H; Ihara T; Okafuji T; Okafuji T; Nagai T; Suzuki E; Shimomura K; Ito Y; Miyazaki C
    J Med Virol; 2004 May; 73(1):97-104. PubMed ID: 15042655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemagglutinin-neuraminidase sequence and phylogenetic analyses of mumps virus isolates from a vaccinated population in Singapore.
    Lim CS; Chan KP; Goh KT; Chow VT
    J Med Virol; 2003 Jun; 70(2):287-92. PubMed ID: 12696120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of hemagglutinin-neuraminidase and nucleocapsid protein of vaccine and wild-type mumps virus strains.
    Ivancic-Jelecki J; Santak M; Forcic D
    Infect Genet Evol; 2008 Sep; 8(5):603-13. PubMed ID: 18508415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic characterization of L-Zagreb mumps vaccine strain.
    Ivancic J; Gulija TK; Forcic D; Baricevic M; Jug R; Mesko-Prejac M; Mazuran R
    Virus Res; 2005 Apr; 109(1):95-105. PubMed ID: 15826917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes.
    Vaidya SR; Dvivedi GM; Jadhav SM
    Indian J Med Res; 2016 Jan; 143(1):37-42. PubMed ID: 26997012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus.
    Atrasheuskaya AV; Neverov AA; Rubin S; Ignatyev GM
    Vaccine; 2006 Mar; 24(10):1530-6. PubMed ID: 16266774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic relationships between six genotypes of the small hydrophobic protein gene of mumps virus.
    Örvell C; Tecle T; Johansson B; Saito H; Samuelson A
    J Gen Virol; 2002 Oct; 83(Pt 10):2489-2496. PubMed ID: 12237432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the neutralization capacity of different types of human measles virus vaccine and the epidemic strains].
    Feng Y; Lu YY; Yan JY; Jiang XH; Shi W; Xu CP; Li Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1123-6. PubMed ID: 18396671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.
    Šantak M; Lang-Balija M; Ivancic-Jelecki J; Košutić-Gulija T; Ljubin-Sternak S; Forcic D
    Epidemiol Infect; 2013 Jun; 141(6):1298-309. PubMed ID: 22954346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.
    Cui A; Zhu Z; Mao N; Si Y; Ma Y; Hu Y; Deng X; Wang L; Zeng L; Zhang Y; Xu W
    Vaccine; 2018 Sep; 36(38):5725-5731. PubMed ID: 30122648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Virus strain specific serum neutralizing antibodies in children and adolescents immunized with a Russian mumps vaccine].
    Otrashevskaia EV; Krasil'nikov IV; Ignat'ev GM
    Vopr Virusol; 2010; 55(6):15-9. PubMed ID: 21381334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine.
    Somboonthum P; Yoshii H; Okamoto S; Koike M; Gomi Y; Uchiyama Y; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2007 Dec; 25(52):8741-55. PubMed ID: 18053621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phylogenetic analysis of clinical mumps virus isolates from vaccinated and non-vaccinated patients with mumps during an outbreak, Switzerland 1998-2000.
    Utz S; Richard JL; Capaul S; Matter HC; Hrisoho MG; Mühlemann K
    J Med Virol; 2004 May; 73(1):91-6. PubMed ID: 15042654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of mumps virus from mumps-vaccinated individuals to close contacts.
    Fanoy EB; Cremer J; Ferreira JA; Dittrich S; van Lier A; Hahné SJ; Boot HJ; van Binnendijk RS
    Vaccine; 2011 Nov; 29(51):9551-6. PubMed ID: 21983359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.